Peng, F., Wu, J., Lian, H., Wu, S., Niu, S., Xing, X., Yang, W., Song, W., Li, Y., Yu, H., Feng, S., Wang, X., Chen, W., Ye, W., Yu, T., Liufu, W., Cheng, C., Bao, Y. (2025). Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial. Nature Communications. https://doi.org/10.1038/s41467-025-65206-z